
10.000+ funcionários
💊 Farmacêutico
🏥 Saúde
🧬 Biotecnologia
💰 $6.500.000 Post-IPO Debt - Eli Lilly em 2024-02
Pharmaceuticals • Healthcare • Biotechnology
Eli Lilly and Company é uma empresa farmacêutica multinacional que pesquisa, desenvolve, fabrica e comercializa medicamentos de prescrição em várias áreas terapêuticas, incluindo diabetes, oncologia, imunologia, neurociência e dor. Com sede em Indianápolis, Indiana, Lilly é conhecida por sua extensa P&D, desenvolvimento clínico e comercialização global de medicamentos biológicos e de pequenas moléculas. A empresa foca na descoberta de medicamentos, ensaios clínicos, aprovações regulatórias e fabricação e distribuição farmacêutica em larga escala.
🕒 Setembro 2
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $265.500 - $453.200 / ano
⏰ Tempo Integral
🟠 Sênior
🔴 Especialista
👔 Vice-presidente
👻 Score fantasma 14%
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

10.000+ funcionários
💊 Farmacêutico
🏥 Saúde
🧬 Biotecnologia
💰 $6.500.000 Post-IPO Debt - Eli Lilly em 2024-02
Pharmaceuticals • Healthcare • Biotechnology
Eli Lilly and Company é uma empresa farmacêutica multinacional que pesquisa, desenvolve, fabrica e comercializa medicamentos de prescrição em várias áreas terapêuticas, incluindo diabetes, oncologia, imunologia, neurociência e dor. Com sede em Indianápolis, Indiana, Lilly é conhecida por sua extensa P&D, desenvolvimento clínico e comercialização global de medicamentos biológicos e de pequenas moléculas. A empresa foca na descoberta de medicamentos, ensaios clínicos, aprovações regulatórias e fabricação e distribuição farmacêutica em larga escala.
• Define and lead the integrated clinical development strategy for Lilly’s Neuroscience Pain early-phase portfolio from discovery through Phase 2 • Establish governance frameworks and decision-making processes, including go/no-go decisions and stage-gate reviews • Provide senior leadership visibility into portfolio health, pipeline gaps, and development opportunities • Align clinical strategy with long-range business objectives across Lilly Research Laboratories and the Medicines Development Unit • Drive full clinical implementation of the Pain portfolio using innovative and accelerated development approaches • Integrate tissue biomarkers and diagnostics into Pain development programs • Align clinical plans with business unit and Lilly Research Laboratories priorities, including Draft Launch Labels and Value Propositions • Define external portfolio focus across priority biology, novel modalities, diagnostics, and academic collaborations • Establish business development areas and academic partnerships in Pain • Prioritize opportunities based on scientific opportunity, strategic fit, risk, timing, and unmet medical need • Lead execution and integration of partnerships and collaborations • Lead interactions with global regulatory bodies and governmental agencies • Engage external medical and scientific experts in molecule development and clinical trial implementation • Lead scientific data disclosure strategy, including protocols, study reports, publications, and regulatory submissions • Represent Lilly Neuroscience in external scientific forums and meetings • Oversee compliance with adverse event reporting requirements • Integrate early-stage Pain program strategy across Neuroscience and align it with business unit priorities • Drive alignment on governance milestones, go/no-go frameworks, and stage-gate reviews • Manage portfolio-level risk assessment and scenario planning for early-stage pain investments • Establish strategy for the Neuronal Health emerging therapeutic area • Champion early portfolio Pain assets across cross-functional teams and external collaborators • Build, lead, and develop a high-caliber cross-functional team • Serve as a senior role model and culture carrier • Evolve capabilities, frameworks, and operating models for identifying, evaluating, and advancing Pain programs • Coach leaders and teams on portfolio thinking, translational science, and trade-off-based decision making • Foster collaboration across R&D, Medical Affairs, Commercial, Corporate Affairs, and Enterprise External Innovation • Advise senior stakeholders and influence decisions through scientific credibility, insight, and synthesis
• Medical Doctor with board eligibility or certification in a medical specialty relevant to the role, or comparable post-medical school clinical training relevant to the country of hiring • U.S.-trained physicians must have achieved board eligibility or certification • Non-U.S.-trained physicians must have completed education and training at a medical school that meets LCME requirements • 12+ years of progressive experience in analgesic clinical development or pharmaceutical medicine • Deep therapeutic area expertise in pain, including chronic pain • Leadership in early-phase clinical development strategy and portfolio delivery • Ability to influence senior leaders and shape strategic decisions in complex, matrixed organizations • Strong interpersonal, organizational, and negotiation skills • Excellent written and verbal English communication • Track record of leading and influencing cross-functional teams at a senior level • Willingness to engage in domestic and international travel as needed • Knowledge of drug development with a specific focus on early development • Background in external innovation strategy, academic collaborations, or business development in neuroscience or pain • Familiarity with RNA silencing, gene therapy, and novel delivery approaches • Comfort operating with ambiguity and establishing direction in evolving scientific spaces • Track record of driving alignment across R&D, Medical, Commercial, and Corporate Affairs • Experience leveraging data, analytics, and emerging technologies to inform clinical strategy and prioritization
• Company bonus depending, in part, on company and individual performance • Company-sponsored 401(k) • Pension • Vacation benefits • Medical benefits • Dental benefits • Vision benefits • Prescription drug benefits • Healthcare flexible spending accounts • Dependent day care flexible spending accounts • Life insurance and death benefits • Time off and leave of absence benefits • Employee assistance program • Fitness benefits • Employee clubs and activities
Candidatar-se🕒 Setembro 2
VP of Sales leading enterprise SaaS sales for Betterworks, an HR software company. Coaching account executives, shaping go-to-market strategy, and winning Fortune 500 customers.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Setembro 2
Vice President leading global compensation, equity, benefits, and rewards strategy at Sophos. Building the Total Rewards team and improving analytics, automation, and employee experience.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $234.000 - $390.000 / ano
💰 Post-IPO Equity em 2021-08
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Setembro 2
Regional sales executive owning enterprise healthcare sales across the Eastern U.S. for Rad AI’s AI-powered radiology workflow solutions. Driving quota, executive relationships, pipeline, forecasting, and expansion.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $300.000 - $350.000 / ano
💰 $25.000.000 Series A em 2021-11
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Setembro 1
Vice President building executive partnerships for Caris Life Sciences’ Precision Oncology Alliance. Developing strategic collaborations across academic institutions and cancer centers nationwide.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $240.000 - $260.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Setembro 1
Enterprise ad-tech sales executive driving net-new revenue from Comscore 250 publishers. Advising digital media leaders on Freestar’s programmatic monetization solutions and yield optimization.
🇺🇸 Estados Unidos – Remoto (EUA)
💰 Private Equity Round em 2021-01
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório